Company
Fleury SA
Headquarters: Sao Paulo, SP, Brazil
Employees: 16,000
CEO: Ms. Jeane Tsutsui
Market Cap
R$8.22 Billion
BRL as of July 1, 2024
US$1.45 Billion
Fleury SA Categories
Brazil Healthcare Medical Instruments & SuppliesBrazil Healthcare Brazil Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $154.23 B |
| EssilorLuxottica SA | $98.99 B |
| Becton, Dickinson and Company | $65.82 B |
| Alcon Inc. | $43.72 B |
| HOYA Corp | $42.76 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, and clinical analysis, health management, and medical care areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It offers laboratory and image exam, diagnostic information, check-up and reference laboratory, dental imaging exam, dental radiology, and diagnostic imaging services. As of December 31, 2019, the company had 245 patient service centers and 24 operations in hospitals under the Fleury, Labs a+, Felippe Mattoso, Lafe, a+SP, Campana, Weinman, a+, Serdil, a+ and Diagmax, IRN/ CPC, Diagnosson a+, and Inlab brand names. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Fleury SA has the following listings and related stock indices.
Stock: Bovespa: FLRY3 wb_incandescent